Intellia Therapeutics (NASDAQ:NTLA) is preparing to release its quarterly earnings on Thursday, 2026-02-26. Here’s a brief overview of what investors should keep in mind before the announcement.
Analysts expect Intellia Therapeutics to report an earnings per share (EPS) of $-0.97.
The announcement from Intellia Therapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It’s worth noting for new investors that guidance can be a key determinant of stock price movements.
Performance in Previous Earnings
During the last quarter, the company reported an EPS beat by $0.08, leading to a 22.73% drop in the share price on the subsequent day.
Here’s a look at Intellia Therapeutics’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -1.00 | -1.02 | -1.27 | -1.32 |
| EPS Actual | -0.92 | -0.98 | -1.10 | -1.27 |
| Price Change % | -22.73 | -5.85 | -1.93 | -7.09 |
Market Performance of Intellia Therapeutics’s Stock
Shares of Intellia Therapeutics were trading at $13.58 as of February 24. Over the last 52-week period, shares are up 24.86%. Given that these returns …